Partners and cooperation


Please note: due to Russia's invasion of Ukraine, and in line with the EU position, ongoing and planned bilateral engagement between the EUDA and representatives of Russia and Belarus has been suspended with immediate effect.

Cooperation with EU institutions, the Reitox network (30 national drug monitoring centres), candidate and potential candidates to the EU, European Neighbourhood Policy (ENP) area countries,and regional and international organisations was an important activity for the EUDA’s predecessor, the EMCDDA, starting in 1993.

The EUDA’s founding regulation stresses that the agency will be active in international fora, offering scientific and evidence-based tools for the development and implementation of the external dimension of the EU’s drugs policy, to ensure the efficient and coherent implementation of the Union’s drugs policy. This means developing strong relations with international partners. This section presents the EUDA’s main collaborators and provides an overview of the numerous activities and projects implemented with partners worldwide. It also provides basic information on their mandates and core tasks.

Information pages on partners and cooperation

More about our partners and cooperation

EU institutions and agencies

The EUDA works closely with the European Union institutions and agencies. This active cooperation means that the agency can provide constant assistance by supplying the Member States and the Community with more reliable and comparable information. In return, the agency’s contributions in the field of information on drugs are broadly disseminated at European level.

Reitox network

The EUDA coordinates and relies on some 30 national monitoring centres (the EUDA network of national focal points) to gather and analyse country data according to common data-collection standards and tools. The results of this national monitoring process are fed to the agency for analysis and are ultimately released in the European Drug ReportStatistical BulletinCountry Drug Reports and many other outputs.

International partners

The EUDA collaborates with numerous international partners, often within the framework of formal cooperation agreements supplemented by practical joint work programmes. Cooperation ranges from the exchange of information and methodologies, via ad hoc technical collaboration on specific supranational projects, to close participation in the EUDA’s routine data collection activities. The overall objective of this cooperation is to develop a better understanding of the changing drugs phenomenon worldwide and to ensure the EU is prepared for new threats as they appear.

Third countries

The EUDA cooperates with candidate and potential candidates to the EU as part of their accession process to the EU, with neighbouring countries of the European Neighbourhood Policy and with other non-EU countries on the basis of bilateral agreements. Cooperation ranges from the implementation of technical assistance projects to ad hoc training or consultative support. This cooperation aims to share the EUDA monitoring practices, guidelines, data collection tools, and support the countries in setting up their national drug information systems.

Further reading


*Kosovo: this designation is without prejudice to positions on status, and is in line with UNSCR 1244 and the ICJ Opinion on the Kosovo declaration of independence.
*Palestine: this designation shall not be construed as recognition of a State of Palestine and is without prejudice to the individual positions of the Member States on this issue.